Dermatitis News

Patients with atopic dermatitis and plaque psoriasis who were treated with a topical phosphodiesterase 4 inhibitor exhibited significant improvement, according to a study.

ANAHEIM, Calif. — A woman who used an acrylate screen protector on her cell phone developed a rash on her face and fingers, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

A new drug application has been submitted to the FDA for oral DFD-29 for the treatment of rosacea, Journey Medical announced in a press release.

The FDA approved multiple products for dermatologic indications this year.

Two new practice parameters from a joint task force published in Annals of Allergy, Asthma & Immunology provide evidence-based recommendations for the diagnosis and management of anaphylaxis and atopic dermatitis.

Patients treated with phototherapy without psoralens do not experience higher incidence rates of skin cancer compared with the general population, according to a study.

The FDA has approved Zoryve for the treatment of seborrheic dermatitis in individuals aged 9 years and older, Arcutis announced in a press release.

The FDA approved an expanded indication for tralokinumab-ldrm to include children aged 12 to 17 years with moderate to severe atopic dermatitis not adequately controlled with topical therapies, according to a press release from Leo Pharma.

Pediatric patients with severe atopic dermatitis experienced higher rates of itch, pain, sleep disturbances and missed school days compared with those with mild disease, according to a study.

IMIDomics and Bristol Myers Squibb have expanded their partnership to include Sjögren's syndrome and atopic dermatitis in their research and development efforts for inflammatory diseases, the companies announced in a press release.